Announcing future EASL Congress dates
The EASL Congress has been gathering experts from around the world to beat liver disease, since 1966. It has since become the place to be, to learn, share and interact with the…
Bringing Care to All European Patients: EASL Advocacy Events for Liver Cancer Awareness Month
This October 2022, in honour of Liver Cancer Awareness Month, EASL participated in organising two important advocacy events aimed at identifying and implementing strategies to enhance awareness of liver cancer and engage…
Liver cancer cases and deaths projected to rise by more than 55% by 2040
Amsterdam, October 6, 2022 – A new analysis reveals that primary liver cancer was among the top three causes of cancer death in 46 countries in 2020 and the number of people…
United Action for Better Health in Europe
On 12-14 September 2022, representatives from civil society, partnering organizations, and the 53 Member States of the WHO European Region met in Tel Aviv, Israel for the 72nd governance session. The session…
Living donor transplantation offers a safe alternative for liver transplant patients
Amsterdam, September 26, 2022 – Demand for donor livers for transplant patients outstrips supply with over 15% of waitlist patients dying after a year. A new international study offers support for increasing…
Introducing the new EASL Membership structure
From the very beginning, EASL’s mission has been to be the “Home of Hepatology”. Providing education to everyone interested in hepatology and engaging with all stakeholders in the liver field wherever they…
Treatment in Pregnancy for Hepatitis C (TiP-HepC) Clinical Case Registry
Although DAA medications have demonstrated excellent safety and efficacy in non-pregnant individuals, they are not currently approved for HCV treatment in pregnant women due to a lack of safety data. Clinical trials…